Moreno-PĂ©rez, D.; Korobova, A.; Croche-Santander, F.d.B.; CordĂłn-MartĂnez, A.; DĂaz-Morales, O.; MartĂnez-Campos, L.; PĂ©rez-González, E.; MartĂnez-Padilla, M.d.C.; Santos-PĂ©rez, J.L.; Brioso-Galiana, J.;
et al. Nirsevimab Prophylaxis for Reduction of Respiratory Syncytial Virus Complications in Hospitalised Infants: The Multi-Centre Study During the 2023–2024 Season in Andalusia, Spain (NIRSEGRAND). Vaccines 2025, 13, 175.
https://doi.org/10.3390/vaccines13020175
AMA Style
Moreno-PĂ©rez D, Korobova A, Croche-Santander FdB, CordĂłn-MartĂnez A, DĂaz-Morales O, MartĂnez-Campos L, PĂ©rez-González E, MartĂnez-Padilla MdC, Santos-PĂ©rez JL, Brioso-Galiana J,
et al. Nirsevimab Prophylaxis for Reduction of Respiratory Syncytial Virus Complications in Hospitalised Infants: The Multi-Centre Study During the 2023–2024 Season in Andalusia, Spain (NIRSEGRAND). Vaccines. 2025; 13(2):175.
https://doi.org/10.3390/vaccines13020175
Chicago/Turabian Style
Moreno-PĂ©rez, David, Aleksandra Korobova, Francisco de Borja Croche-Santander, Ana CordĂłn-MartĂnez, Olga DĂaz-Morales, Leticia MartĂnez-Campos, Elena PĂ©rez-González, MarĂa del Carmen MartĂnez-Padilla, Juan Luis Santos-PĂ©rez, Jaime Brioso-Galiana,
and et al. 2025. "Nirsevimab Prophylaxis for Reduction of Respiratory Syncytial Virus Complications in Hospitalised Infants: The Multi-Centre Study During the 2023–2024 Season in Andalusia, Spain (NIRSEGRAND)" Vaccines 13, no. 2: 175.
https://doi.org/10.3390/vaccines13020175
APA Style
Moreno-PĂ©rez, D., Korobova, A., Croche-Santander, F. d. B., CordĂłn-MartĂnez, A., DĂaz-Morales, O., MartĂnez-Campos, L., PĂ©rez-González, E., MartĂnez-Padilla, M. d. C., Santos-PĂ©rez, J. L., Brioso-Galiana, J., Sánchez-CĂłdez, M. I., Del Diego-Salas, J., Rivera-Izquierdo, M., & Lorusso, N.
(2025). Nirsevimab Prophylaxis for Reduction of Respiratory Syncytial Virus Complications in Hospitalised Infants: The Multi-Centre Study During the 2023–2024 Season in Andalusia, Spain (NIRSEGRAND). Vaccines, 13(2), 175.
https://doi.org/10.3390/vaccines13020175